Abstract
Photofrin®-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that neutrophils are indispensable for its anti-tumour effectiveness. We decided to evaluate the extent of the anti-tumour effectiveness of PDT combined with administration of granulocyte colony-stimulating factor (G-CSF) as well as the influence of Photofrin®and G-CSF on the myelopoiesis and functional activity of neutrophils in mice. An intensive treatment with G-CSF significantly potentiated anti-tumour effectiveness of Photofrin®-based PDT resulting in a reduction of tumour growth and prolongation of the survival time of mice bearing two different tumours: colon-26 and Lewis lung carcinoma. Moreover, 33% of C-26-bearing mice were completely cured of their tumours after combined therapy and developed a specific and long-lasting immunity. The tumours treated with both agents contained more infiltrating neutrophils and apoptotic cells then tumours treated with either G-CSF or PDT only. Importantly, simultaneous administration of Photofrin®and G-CSF stimulated bone marrow and spleen myelopoiesis that resulted in an increased number of neutrophils demonstrating functional characteristics of activation. Potentiated anti-tumour effects of Photofrin®-based PDT combined with G-CSF observed in two murine tumour models suggest that clinical trials using this tumour therapy protocol would be worth pursuing. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahmad N, Feyes DK, Agarwal R and Mkhtar H (1998) Photodynamic therapy results in induction of waf1/cip1/p21 leading to cell cycle arrest and apoptosis. Proc Natl Acad Sci USA 95: 6977–6982
Albert MI, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL and Bhardwaj N (1998) Immature dendritic cells phagocytose apoptotic cells via ανβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188: 1359–1368
Ben-Hur E, Heldman E, Crane SW and Rosenthal I (1988) Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy. FEBS Lett 236: 105–108
de Vree WJA, Essers MC, de Bruijn HS, Star WM, Koster JF and Sluiter W (1996 a) Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res 56: 2908–2911
de Vree WJA, Fontijne-Dorsman ANRD, Koster JF and Suiter W (1996 b) Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. Br J Cancer 73: 2908–2911
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q (1998) Photodynamic therapy. J Natl Acad Sci 90: 889–905
Faddy C, Reisser D and Marin F (1990) Non-activated neutrophils kill syngeneic colon tumour cells by the release of low molecular weight factor. Immunobiology 181: 1–12
Fingar VH, Wieman TJ, Wiehle SA and Cerrito PB (1992) The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 52: 4914–4921
Fingar VH, Wieman TJ and Haydon PS (1997) The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin. Photochem Photobiol 66: 4914–4921
Foster TH, Primavera MC, Marder VJ, Hilf R and Sporn LA (1991) Photosensitized release of von Willebrand factor from cultured human endothelial cells. Cancer Res 51: 3261–3266
Gołąb J, Stokłosa T, Zagożdżon R, Kaca A, Giermasz A, Pojda Z, Machaj E, Da˛browska A, Feleszko W, Lasek W, Iwan-Osiecka A and Jakóbisiak M (1998 a) G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumour activity in a melanoma model in mice. Ann Oncol 9: 63–69
Goła˛b J, Stokłosa T, Zagoz·dz·on R, Kaca A, Kulchitska LA, Feleszko W, Kawiak J, Hoser G, Głowacka E, Da˛browska A, Giermasz A, Lasek W and Jakóbisiak M (1998 b) Granulocyte-macrophage colony-stimulating factor potentiates antitumour activity of interleukin-12 in melanoma model in mice. Tumour Biol 19: 77–87
Granville DJ, Levy JG and Hunt DWC (1997) Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ 4: 623–628
Henderson BW and Dougherty TJ (1992) How does photodynamic therapy work?. Photochem Photobiol 55: 623–628
Hunt DWC, Sorrenti RA, Renke ME, Waterfield E and Levy JG (1995) Accelerated myelopoietic recovery in irradiated mice treated with photofrin. Int J Immunopharmacol 17: 33–39
Hunt DWC, Jiang H and Levy JG (1998) Photofrin®increasess murine spleen cell transferrin receptor expression and responsiveness to recombinant myeloid and erythroid growth factors. Immunopharmacology 37: 267–278
Kashtan H, Haddad R, Yossiphov Y, Bar-On S and Skornick Y (1996) Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment. Dis Colon Rectum 39: 379–383
Korbelik M (1996) Induction of tumour immunity by photodynamic therapy. J Clin Laser Med Surg 14: 329–334
Korbelik M and Dougherty GJ (1999) Photodynamic therapy-mediated immune response against mouse tumours. Cancer Res 59: 1941–1946
Korbelik M, Krosl G, Krosl J and Dougherty GJ (1996) Role of host lymphoid populations in the response of mouse emt6 tumour to photodynamic therapy. Cancer Res 56: 5647–5652
Korbelik M, Naraparaju VR and Yamamoto N (1997) Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 75: 202–207
Krosl G, Korbelik M and Dougherty GJ (1995) Induction of immune cell infiltration into murine SSCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 71: 549–555
Krosl G, Korbelik M, Krosl J and Dougherty GJ (1996) Potentiation of photodynamic therapy-elicited antitumour response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res 56: 3281–3286
Nseyo U, Whalen RK, Duncan MR, Berman B and Lundahl SL (1990) Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 36: 167–171
Ochsner M (1997) Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol 39: 1–18
Pass HI (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 85: 443–456
Reynolds T (1997) Photodynamic therapy expands its horizons. J Natl Cancer Inst 89: 112–114
Stoppacciaro A, Melani C, Parenza M, Mastracchio A, Bassi C, Baroni C, Parmiani G and Colombo MP (1993) Regression of an established tumour genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon γ. J Exp Med 178: 151–161
Welte K, Gabrilove J, Bronchud MH and Platzer E (1996) Filgrastim (r-methuG-CSF): the first 10 years. Blood 88: 1907–1929
Zilocchi C, Stoppacciaro A, Chiodoni C, Parenza M, errazzini N and Colombo MP (1998) Interferon γ-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and granulocyte/macrophage colony-stimulating factor. J Exp Med 188: 133–143
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Goląb, J., Wilczyński, G., Zagożdżon, R. et al. Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer 82, 1485–1491 (2000). https://doi.org/10.1054/bjoc.1999.1078
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1078
Keywords
This article is cited by
-
Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents
Biophysical Reviews (2017)
-
Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment
Tumor Biology (2015)
-
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
Apoptosis (2010)
-
Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity
Oncogene (2006)
-
Photodynamic therapy and anti-tumour immunity
Nature Reviews Cancer (2006)